View By Speaker
M. Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
M. Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
Jose Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
C. Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
Jose Maldonado, MDAssociate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center| Tuesday, November 3 09:15-10:30 a.m. |
223 - Neuropsychiatric Masquerades: Medical and Neurological Disorders that Present with Psychiatric Symptoms Part 1 NP
1.25 credits - Room: Mandalay Bay Ballroom KL |
Jose Maldonado, MD, Associate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center
|
Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies. By participating in this activity, attendees will be able to: - Recognize the most common infectious disorders presenting with psychiatric symptoms;
- Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
- Recommend the research-based, effective treatment options for these conditions.
|
| Tuesday, November 3 10:45-12:00 p.m. |
233 - Neuropsychiatric Masquerades: Medical and Neurological Disorders that Present with Psychiatric Symptoms Part 2 NP
1.25 credits - Room: Mandalay Bay Ballroom KL |
Jose Maldonado, MD, Associate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center
|
Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies. By participating in this activity, attendees will be able to: - Recognize the most common infectious disorders presenting with psychiatric symptoms;
- Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
- Recommend the research-based, effective treatment options for these conditions.
|
| Wednesday, November 4 07:45- 09:00 a.m. |
312 - Delirium: An Update PD
1.25 credits - Room: Lagoon ABCGHI |
Jose Maldonado, MD, Associate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center
|
Psychiatrists are asked to render opinions and help in the management and treatment of a number of conditions which etiology may be primarily neurological, but its manifestations clearly psychiatric. Delirium is a transient, reversible organic mental syndrome caused by dysfunction in cerebral metabolism, characterized by an acute or subacute onset. Features of delirium include disturbance of consciousness, change in cognition, perceptual disturbances, global cognitive impairment, attentional abnormalities, increased or decreased psychomotor activity, and sleep-wake cycle disruption. Alcohol, medication intoxication, and withdrawal stages will be given special attention, as possible and common causes of delirium. The inappropriate treatment usually leads to improper treatment, thus delaying appropriate management. Upon the completion of this activity, participants will be able to: - Understand the pathophysiology of delirium;
- Understand the research-based, effective treatment options for delirium, including the use of atypical antipsychotic and other novel agents.
- Learn research proven preventing techniques.
|
|
